|
Dear VIJAY PITHADIA: Your November 2014 digital issue of P&T journal is available. This issue contains: Feature articles - Letter to the Editor
PERSPECTIVE - The Changing Roles of P&T Committees
A Look Back at the Last Decade and a Look Forward to 2020
Changes related to market forces, regulatory initiatives, and the Affordable Care Act have significantly altered the traditional work of P&T committees. Redefined issues of quality, cost, and access will become even more important in the coming years.
- Epilepsy Management: Newer Agents, Unmet Needs, And Future Treatment Strategies
Drug therapy aids most epilepsy patients, but unmet challenges include drug-resistant epilepsy, adverse reactions, drug interactions, the need to better identify epileptic syndromes, and a lack of agents to prevent epilepsy and its comorbidities.
PIPELINE PLUS - Modest Growth Seen in Epilepsy Market
The epilepsy market's $4.2 billion in global sales in 2012 is expected to increase to $5.4 billion by 2022. In a market crowded with products, pharmaceutical companies have shifted their focus to devising safe adjunctive therapies for refractory patients.
MEETING HIGHLIGHTS - European Society of Cardiology and Transcatheter Cardiovascular Therapeutics
In these two major cardiology meetings, the pharmacology emphasis was strong on balancing risks of stroke and bleeding in treating heart attacks and atrial fibrillation.
BOOK REVIEW - The Same but Not the Same
In his exhaustively researched new book, Generic: The Unbranding of Modern Medicine, physician-historian Jeremy A. Greene, MD, PhD, explores the rise of generic drugs in the U.S. and our evolving understanding of "generic equivalence."
P&T SNAPSHOT - Survey Reveals Trends in Eye Care
A survey on the eye care market shows areas of agreement and a few sharp differences among ophthalmologists, optometrists, and managed care executives.
Plus our regular columns: Medication Errors, Prescription: Washington, New Drugs/Drug News/New Medical Devices, Pharmaceutical Approval Update, and Drug Forecast.
Click here to begin reading the current issue.
Click here to subscribe to P&T journal
Call for Papers
P&T is accepting article submissions from its readers. We welcome a wide variety of manuscripts, including drug class reviews, disease state management reviews, pharmacoeconomic analyses, outcomes research evaluations, DUEs, P&T committee experiences, commentaries, book reviews, and letters to the editor. Please contact Sonja Sherritze, via phone (267-685-2779) or mobile 267-907-5642) or e-mail (ssherritze@medimedia.com) for more information.
We hope you enjoy this issue of P&T. If you have any comments or questions about this digital format, please e-mail us at mail@ptcommunity.com. Sonja Sherritze Editor |
Posts
